cfDNA extraction from plasma (Round 2)
Applicable for all labs extracting cfDNA from plasma. Two rounds of EQA per year – purchase each separately.
This EQA will be distributed in SEPTEMBER 2025.
Charcot-Marie-Tooth disease / Hereditary Neuropathy with liability for Pressure Palsies (CMT/HNPP) (PMP22 and optional gene panel testing for other CMT-associated genes).
Applicable to all labs undertaking molecular genetic testing for these disorders.
Colorectal cancer [Tissue]
Applicable to all labs undertaking molecular testing for this cancer using FFPE tissue.
Myotonic dystrophy (DM) (Types 1 and/or 2)
Applicable to all labs undertaking molecular genetic testing for these disorders.
Fragile X Syndrome (FRAX)
Applicable to all labs undertaking molecular genetic testing for this syndrome (including those which cannot detect the ENTIRE range of expansions +/- methylation patterns).
Friedreich Ataxia (FRDA)
Applicable to all labs undertaking molecular genetic testing for this disorder.
